Ketamine-Assisted Couple Therapy Training by Enamory
This educational workshop is the first step toward certification in the Enamory model of Ketamine-Assisted Couple Therapy (couples’ KAP). Learn how to conduct an assessment and build a case formulation for couples’ KAP, prepare a couple with a healing mindset and setting, choose a dosing procedure to support the treatment goals, and support dyadic integration. […] The post Ketamine-Assisted Couple Therapy Training by Enamory appeared first on Psychedelics Today.
External link. We are not responsible for the content.
Read more ↗More From Psychedelics Today
The Psychedelic Writers Guild’s Denver Mixer
Join The Psychedelic Writers Guild for a Denver Mixer on Thursday, April 9, hosted by Psychedelic State(s) of America...
The Mushroom Cure – Special Live Filming
The true story of one man’s quest to cure his severe OCD with psychedelics “Mines a great deal of laughter from disab...
Esme Dark – Psychedelics, Somatics and the Shadow
Dr. Esme Dark joins Kyle Buller for a conversation on psychedelic therapy, somatic psychotherapy, and shadow work. Ba...
Latest News
The Personality Shift That Happens First
Welcome to the Psychedelic Blog. I write about the impact of Psychedelics on Grieving, Relationships, Culture & Death.
Psychedelic Reform Without Home Grow Is Still Prohibition
If you can’t grow your own medicine, pharma corporations and the Drug War still win...at our expense. [...] Read More...
Your Passport to the World’s Most Psychedelic Gatherings
A curated trip through music, art, and radical connection worldwide. [...] Read More... The post Your Passport to the...
Why is the Message Not to Take Life So Seriously Common on Psychedelics?
Psychedelics can enhance humour and laughter, which may help people bond socially, gain new perspectives, loosen atta...
Meet Yopo, Ayahuasca's Grandfather: the Sacred Plant No One's Heard Of.
Yopo, the oldest of them all, the grandfather of the entire lineage, the medicine with the longest unbroken ceremoni...
How Gilgamesh Landed a $1.2B AbbVie Deal in Psychedelics
Jonathan Sporn (CEO + Founder of Gilgamesh Pharma) joins for a deep dive into next-gen psychedelic medicines, why dur...